about
A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery.MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.Gadolinium-based contrast agents for magnetic resonance cancer imaging.Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications.Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane as a Long Circulating High Relaxivity MRI Contrast Agent.Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization.Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery.Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy.EDB Fibronectin Specific Peptide for Prostate Cancer Targeting.Molecular imaging of the tumor microenvironment.Integration of nanoassembly functions for an effective delivery cascade for cancer drugs.Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy.Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery.Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene Therapy.A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers.Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.Detailed investigation on how the protein corona modulates the physicochemical properties and gene delivery of polyethylenimine (PEI) polyplexes.Albumin-Stabilized Metal-Organic Nanoparticles for Effective Delivery of Metal Complex Anticancer DrugsDegradable dual pH- and temperature-responsive photoluminescent dendrimersIntegration of Polymerization and Biomineralization as a Strategy to Facilely Synthesize Nanotheranostic AgentsGlutathione-Specific and Intracellularly Labile Polymeric Nanocarrier for Efficient and Safe Cancer Gene DeliveryEnzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacyEnzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic TumorsSingle-step formulation of levodopa-based nanotheranostics - strategy for ultra-sensitive high longitudinal relaxivity MRI guided switchable therapeuticsReactive Oxygen Species (ROS)-Responsive Charge-Switchable Nanocarriers for Gene Therapy of Metastatic CancerTuning the Brightness and Photostability of Organic Dots for Multivalent Targeted Cancer Imaging and Surgery
P50
Q33623674-3E525F72-2F39-4D3C-A433-6B34DD860221Q33734954-DE2D5AA2-332B-4181-A8D8-3FE7670AD1B5Q33768695-C8008565-3728-409F-979A-E9AE8AC8F659Q34703525-1327EA32-FE0A-429E-8E6B-A9417782F7C2Q36018529-2283A463-766B-4456-84E9-6662C5A13F57Q36510352-01DBA042-A3BA-41AC-968A-4D179BDCC07EQ36555415-755F47DF-85F3-44CE-BC0F-6D3C18E62824Q38270095-FD2DBEED-37F6-47E5-BD6C-EF237B0FE0B4Q38642313-323E56A4-5FEE-404A-88D7-C44A471801CDQ38716380-3D83B666-9B0A-4C76-BF06-DB159C34F665Q38753639-1724CEFF-C3E1-4E58-8F0A-28A61A917337Q38777471-EEF4589F-3C4E-48DB-8AE0-4645EC03BACEQ38811957-A0497E23-F377-406B-858E-40917B44ACE4Q38826680-FAEAD7A2-F7A7-48C5-B7A3-D93931228772Q38890135-E290EF95-FB0D-4E86-918A-501EF08CC720Q38920565-F6036B3C-095C-4753-B4E5-7EC92CDA3514Q38946689-D1D7CE38-48EB-44DE-9311-84F01F3005D5Q38962983-81EE228F-ABD3-4431-B80E-A3F5DB400009Q39223698-2A60F2AE-9570-469C-80D7-2491E40CDD11Q45861301-BD0F16CA-0EB2-4758-88CA-AB71A117E0C9Q46317390-2CF3226D-FE02-45E0-91D2-559A1FE91059Q47399839-61D45C85-1D95-44D8-BFA5-5834144A6B7AQ54204829-4D724B45-627F-4692-87A4-F59CBD1D04EEQ57023454-AF2A8775-82AF-448A-9809-22928BCCDE75Q83782588-37C529C6-5E70-43E1-893D-FFDB284ADB52Q90208537-F3C2C1EF-E538-4686-A055-512C7B82D06EQ90291115-A9677DDF-75B4-4F26-9221-F73DD309DB6BQ91529646-2AFA00EA-60B9-48BC-BC83-276ABD88DF6BQ91895429-96BA0FE9-570F-4E61-9B3B-C286A8E25413Q92846569-A10AFFF6-42F8-480E-9A75-E7B3F12FA800Q93347269-53A76244-7E69-4AFF-B6E4-5DE7986E5A78Q94479256-27C5AE7F-51D5-4237-AB81-1148950C277C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zhuxian Zhou
@ast
Zhuxian Zhou
@en
Zhuxian Zhou
@es
Zhuxian Zhou
@nl
Zhuxian Zhou
@sl
type
label
Zhuxian Zhou
@ast
Zhuxian Zhou
@en
Zhuxian Zhou
@es
Zhuxian Zhou
@nl
Zhuxian Zhou
@sl
prefLabel
Zhuxian Zhou
@ast
Zhuxian Zhou
@en
Zhuxian Zhou
@es
Zhuxian Zhou
@nl
Zhuxian Zhou
@sl
P1053
F-5412-2015
P106
P2798
P31
P3829
P496
0000-0002-7104-9915
P569
2000-01-01T00:00:00Z